Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard A Lux

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|April 3, 2025
Eberhard A Lux
MMW Fortschritte Der Medizin|April 4, 2024
[Quality of live of palliative outpatient care in Westphalia-Lippe focusing on contentedness of patients and their relatives - a multicenter cohort study]Reinhard Bornemann, Ludmila Kravets, Eberhard A Lux
Journal of Pain Research|August 31, 2016
Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer painMichael A Ueberall, Stefan Lorenzl, Eberhard A Lux, et al.
BMC Clinical Pharmacology|October 6, 2010
Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsOliver Löwenstein, Petra Leyendecker, Eberhard A Lux, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|April 3, 2025
Eberhard A Lux
MMW Fortschritte Der Medizin|April 4, 2024
[Quality of live of palliative outpatient care in Westphalia-Lippe focusing on contentedness of patients and their relatives - a multicenter cohort study]Reinhard Bornemann, Ludmila Kravets, Eberhard A Lux
Journal of Pain Research|August 31, 2016
Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer painMichael A Ueberall, Stefan Lorenzl, Eberhard A Lux, et al.
BMC Clinical Pharmacology|October 6, 2010
Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsOliver Löwenstein, Petra Leyendecker, Eberhard A Lux, et al.
Pageof 1